Osteomalacia as a complication of intravenous iron infusion: a systematic review of case-reports

Keyphrases

• Fibroblast Growth Factor 23 (FGF23) 100%
• Osteomalacia 100%
• Intravenous Iron Therapy 100%
• Randomized Controlled Trial 66%
• Alkaline Phosphatase 66%
• Bone Research 66%
• Mineral Research 66%
• Bone Scan 66%
• Hypophosphatemia 66%
• Low Phosphate 66%
• Pseudofracture 66%
• Adverse Effects 33%
• Embase 33%
• MEDLINE 33%
• Gastrointestinal Diseases 33%
• Severe Cases 33%
• American Society 33%
• Cochrane Database 33%
• Intravenous Iron 33%
• Muscle Pain 33%
• 25(OH) Vitamin D 33%
• High-alkaline 33%
• Reporting Bias 33%
• Bone Pain 33%
• Prolonged Therapy 33%
• Ferric Carboxymaltose 33%
• Saccharated Ferric Oxide 33%
• 1,25(OH)2 Vitamin D 33%
• Web of Science Database 33%
• Iron Polymaltose 33%
• Potential Complications 33%
• Narrative Summary 33%
• Effective Interventions 33%
• Phosphate Levels 33%

Medicine and Dentistry

• Systematic Review 100%
• Infusion 100%
• Osteomalacia 100%
• Fibroblast Growth Factor 23 60%
• Randomized Controlled Trial 40%
• Alkaline Phosphatase 40%
• Bone Scintigraphy 40%
• Hypophosphatemia 40%
• Adverse Event 20%
• Vitamin D 20%
• Narrative 20%
• Clinical Finding 20%
• Myalgia 20%
• Gastrointestinal Disease 20%
• Bone Pain 20%
• Iron Sucrose 20%
• Iron 20%
• Iron Polymaltose 20%
• Ferric Carboxymaltose 20%
• Ergocalciferol 20%